- Total Solution for the Regulated Food, Cannabis & Psychedelic Industry
- Call Us+507 (320)-5092
- Email atmainweb@theracann.solutions
- Office HrsMon - Fri : 9.00am to 18.00pm
4 Palliative Canadians approved for end of life psilocybin therapy through section 56(1) ; First legal medical exemptions for psilocybin in Canada since 1970’s - TheraCann
This “exemption” event marks the thin edge of the wedge that will open this new sector for medical use of plant based entheogen medicine in Canada. To assist Health Canada from avoiding the mistakes made during the development of the legalized cannabis sector, TheraCann International is actively engaged with both entheogen researches and developers for the purpose of leveraging existing R&D licenses for the purpose of providing critical infrastructure including the adaption its existing technologies for the purpose of quickly ramping up legal inventories of plant based entheogen medicine including psilocybin in advance of the large demand.
Contact us now – mainweb@theracann.solutions